ClinicalTrials.gg
RecruitingNCT06693258CARTOUpdated Sep 10, 2026

Study of Transaxillary Robotic Thyroidectomy Versus Standard Open Thyroidectomy: Prospective, Comparative Single-Center Study

An interventional study of thyroidectomy by robotic surgery via axillary approach and thyroidectomy by standard conventional surgery in Carpal Tunnel Surgery, sponsored by Clinique Bizet. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-10.

Sponsored by Clinique Bizet · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Nov 2024; still recruiting 1 year 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim of our study is to evaluate the two surgical approaches, standard thyroidectomy and robotic thyroidectomy, in terms of postoperative pain management, scar quality, quality of life, as well as the occurrence of postoperative complications (hypocalcemia, compressive cervical hematoma and nerve stimulation)

02

Conditions studied

  • Carpal Tunnel Surgery
03

In context

Lead sponsor

Clinique Bizet is the lead sponsor of 16 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Subject aged over 20 years
  • Referred for a thyroidectomy (total or partial)
  • Absence of participation in another clinical study
  • Subject affiliated to a social security scheme or beneficiary of such a scheme
  • Accepts the completion of the various study questionnaires

Exclusion criteria

Exclusion Criteria:

  • Patient under 20 years of age.
  • Patients who have undergone combined radical cervical lymph node dissection
  • Patient with a postoperative wound problem
  • Patient with an underlying systemic disease that may influence the wound healing process
  • Unable to undergo medical follow-up for the study.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Experimental group

    thyroidectomy by robotic surgery via axillary approach

    Procedure: thyroidectomy by robotic surgery via axillary approach

  • Active comparator
    Control group

    thyroidectomy by standard conventional surgery

    Procedure: thyroidectomy by standard conventional surgery

Interventions

  • Procedurethyroidectomy by robotic surgery via axillary approach

    thyroidectomy

  • Procedurethyroidectomy by standard conventional surgery

    thyroidectomy by standard conventional surgery

06

What researchers measure

Primary outcomes

  1. Evaluate the post-operative quality of life at D30 between the two groups

    thyca-Qol

    Time frame: day 30

Secondary outcomes

  1. Total dysphagia score between the two groups

    EAT-10 scale

    Time frame: Day7, Day30 and 3 months

  2. Quality of the scar between the two groups

    Vancouver scale

    Time frame: day 30

  3. Assess the functional recovery of the vocal cords

    fibroscopy

    Time frame: day 7 and day 30

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Nov 2024 (actual). Primary completion is estimated for Dec 2026, 25 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 12, 2024
First posted
Nov 18, 2024
StartActual
Nov 25, 2024
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Sep 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06693258
Lead sponsor
Clinique Bizet
Responsible party
Sponsor
First posted
Nov 18, 2024
Start date
Nov 25, 2024
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Sep 10, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion